NCT05252481

Transcranial Direct Stimulation for Persistent Fatigue Treatment Post-COVID-19

Modulation of Post-COVID-19 Fatigue Using Transcranial Direct Current Stimulation. Transcranial Direct Stimulation for Persistent Fatigue Treatment Post-COVID-19

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 47 (actual)
• Sponsor: Hospital San Carlos, Madrid · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Fatigue is common and disabling in patients with post-COVID syndrome. There is no treatment available at this moment, and fatigue has important consequences. The main aim of this study is to evaluate the changes in the severity of fatigue using non-invasive neuromodulation in patients with post-COVID condition. This is a randomized, parallel, double-blind, placebo-controlled clinical trial using transcranial direct current stimulation. Secondary aims include changes in cognition, depression, and quality of life.

Conditions

• COVID-19

Interventions

Type	Name	Description
DEVICE	Active tDCS	Eight sessions of transcranial current direct stimulation
DEVICE	Sham tDCS	Eight sessions of transcranial current direct stimulation (sham)

Timeline

• Start date: 2022-04-01
• Primary completion: 2022-06-26
• Completion: 2022-07-31
• First posted: 2022-02-23
• Last updated: 2022-08-22

Locations

1 site across 1 country: Spain